PROTAC Linker Design and Optimization

Inquiry

PROTAC Linker Design and Optimization

PROTAC linker is a pivotal component of PROTAC (Proteolysis-Targeting Chimeras) molecules, bridging the target protein ligand and the E3 ligase ligand. CD ComputaBio's PROTAC Linker Design and Optimization Service focuses on creating highly efficient linkers to enhance the stability, flexibility, and overall performance of PROTACs. Leveraging advanced computational tools and expertise, this service ensures the development of PROTACs with optimal pharmacokinetic and pharmacodynamic properties.

Introduction to PROTAC Linker and its Design

The linker in a PROTAC molecule plays a critical role in determining its efficacy by influencing the spatial orientation and binding dynamics between the target protein and the E3 ligase. An optimized linker ensures proper proximity and interaction, enabling efficient ubiquitination and subsequent degradation of the target protein. Designing an effective linker involves balancing multiple factors, including length, chemical composition, rigidity, and flexibility.

Figure 1. PROTAC Linker.Figure 1. PROTAC Linker. (Zografou-Barredo N A, at al., 2023)

Computational Design of PROTAC Linker

Computational approaches, such as molecular modeling, molecular dynamics simulations, and AI-driven algorithms, are essential for evaluating and optimizing these parameters. The computational design of PROTAC linkers has become a key force in promoting progress in this field. Computational design uses a variety of theories and methods such as quantum mechanics and molecular mechanic to deeply analyze the structural characteristics and physicochemical properties of linkers.

Our Services

Successful linker design can significantly enhance the performance of PROTACs, leading to more effective protein degradation and improved therapeutic profiles. CD ComputaBio offers a comprehensive suite of services to support PROTAC linker design and optimization, including:

PROTAC Linker Design

This service focuses on the creation of specialized linker architectures tailored to the unique requirements of specific target proteins and E3 ligases. Utilizing advanced computational modeling and structure-activity relationship (SAR) studies aids in predicting optimal linker configurations, ensuring effective interactions between all components of the PROTAC

PROTAC Linker Optimization

For existing PROTAC linkers, our service aims to enhance their performance. Through computational analysis, modifications are made to improve properties such as pharmacokinetic behavior. This may involve altering the chemical structure of the linker, adding or removing certain functional groups, or adjusting the length based on the feedback from in vitro and in vivo studies.

Advanced Method

Utilizing cutting-edge technologies in computational chemistry and biophysical assays, the methods are robust and multi-faceted. CD ComputaBio offers you the following methods:

Advantages

Interdisciplinary Expertise

A team of experts with backgrounds in medicinal chemistry, structural biology, and pharmacology collaborates to deliver high-quality solutions.

State-of-the-Art Resources

Access to cutting-edge technologies and methodologies ensures up-to-date approaches in PROTAC development.

Collaborative Approach

A focus on client engagement fosters a partnership that aligns project goals with expected outcomes, resulting in a tailored service experience.

CD ComputaBio's PROTAC linker design and optimization service provides a comprehensive solution for developing highly effective PROTAC molecules. This service ensures the creation of PROTACs with enhanced stability, flexibility, and efficacy. Partner with us to unlock the full potential of PROTAC technology and accelerate the development of next-generation targeted protein degraders. If you are interested in our services or have any questions, please feel free to contact us.

Reference:

  1. Zografou-Barredo N A, Hallatt A J, Goujon-Ricci J, et al. A beginner's guide to current synthetic linker strategies towards VHL-recruiting PROTACs. Bioorganic & Medicinal Chemistry, 2023, 88: 117334.
* For Research Use Only.
Related Services
logo
Give us a free call

Send us an email

Copyright © CD ComputaBio. All Rights Reserved.
Top